Printed From BioPortfolio.com
OMEICOS Secures Extension of Series B Financing Round
03:00 EDT 9 Oct 2017 | Bionity
OMEICOS Therapeutics, a Berlin-based biopharmaceutical company developing first-in-class small molecule therapeutics for the prevention and treatment of cardiovascular diseases, today announced that it has secured an extension of its recently closed Series B financing round. The financing by US-base...
Original Article: OMEICOS Secures Extension of Series B Financing Round
